Hyperchromasia is the term pathologists use for a nucleus that looks darker than normal under the microscope. The nucleus is the part of a cell that holds most of its genetic material (DNA). On the standard hematoxylin and eosin (H&E) stain used to examine tissue, a normal nucleus stains an even blue or purple. When a nucleus takes up more of the stain and appears noticeably darker, the pathologist describes it as showing hyperchromasia. The adjective form, hyperchromatic, describes a single dark nucleus and means the same thing.
Hyperchromasia describes what the pathologist saw under the microscope, not a diagnosis on its own. A darker nucleus is a clue, not a conclusion. It can appear in harmless situations as well as in precancerous and cancerous ones, so its meaning depends on the other features the pathologist sees and the context in which it appears. This article explains what causes hyperchromasia, how pathologists recognize it, and what it can and cannot tell you.
What causes hyperchromasia?
The dark color comes from the DNA inside the nucleus. Hematoxylin, the blue-purple part of the H&E stain, binds to DNA, so a nucleus appears darker when it contains extra copies of DNA, when its DNA is packed more densely than usual, or when the nucleus is enlarged and holds more genetic material. These changes can happen for ordinary reasons or as part of an abnormal process, which is why hyperchromasia is always considered alongside other cell features. It can be seen in:
- Injury, irritation, or inflammation — Noncancerous cells can develop darker nuclei when they are stressed or repairing themselves, for example during inflammation or infection. These are called reactive changes.
- Precancerous conditions — Hyperchromasia is often seen in precancerous changes such as dysplasia, in which cells look abnormal but have not become cancer.
- Cancer — Cancer cells frequently show hyperchromasia because they contain abnormal or increased amounts of DNA. In cancer, it usually appears together with other changes, such as enlarged nuclei, irregular shapes, and increased cell division.
How is hyperchromasia identified?
A pathologist identifies hyperchromasia while examining a tissue or cell sample under a microscope after H&E staining. Nuclei that are darker and more intensely stained than those of nearby normal cells are described as showing hyperchromasia. On its own, this feature does not identify what a cell is; it is one of several nuclear features, along with size, shape, and internal structure, that the pathologist weighs together. When hyperchromasia appears with other abnormal nuclear features, it may be described as part of nuclear atypia.
Does hyperchromasia mean cancer?
No. Hyperchromasia does not by itself mean cancer, and it is not harmful on its own. Although cancer cells often show it, cells affected by inflammation, injury, and other noncancerous changes can too. The pathologist decides whether the change is atypia by looking at the whole picture: the other features of the cells, how the tissue is arranged, and the clinical situation. For this reason, seeing the word hyperchromasia in a report does not, on its own, indicate how serious a finding is; that comes from the overall diagnosis.
Questions to ask your doctor
- In my report, was the hyperchromasia part of a benign, precancerous, or cancerous finding?
- What was the overall diagnosis for the sample where this was seen?
- Were other abnormal features, such as nuclear atypia, described along with it?
- Does this finding change what happens next in my care?
- Is any additional testing or follow-up recommended?
Related articles on MyPathologyReport.com
We are proud to partner with:
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name